Abstract:Background: Mutations in recombination-activating gene (RAG) 1 and RAG2 are associated with a broad range of clinical and immunologic phenotypes in human subjects. Objective: Using a flow cytometry-based assay, we aimed to measure the recombinase activity of naturally occurring RAG2 mutant proteins and to correlate our results with the severity of the clinical and immunologic phenotype. Methods: Abelson virus-transformed Rag2-/- pro-B cells engineered to contain an inverted green fluorescent protein (GFP) cassette flanked by recombination signal sequences were transduced with retroviruses encoding either wild-type or 41 naturally occurring RAG2 variants. Bicistronic vectors were used to introduce compound heterozygous RAG2 variants. The percentage of GFP-expressing cells was evaluated by using flow cytometry, and high-throughput sequencing was used to analyze rearrangements at the endogenous immunoglobulin heavy chain (Igh) locus. Results: The RAG2 variants showed a wide range of recombination activity. Mutations associated with severe combined immunodeficiency and Omenn syndrome had significantly lower activity than those detected in patients with less severe clinical presentations. Four variants (P253R, F386L, N474S, and M502V) previously thought to be pathogenic were found to have wild-type levels of activity. Use of bicistronic vectors permitted us to assess more carefully the effect of compound heterozygous mutations, with good correlation between GFP expression and the number and diversity of Igh rearrangements. Conclusions: Our data support genotype-phenotype correlation in the setting of RAG2 deficiency. The assay described can be used to define the possible disease-causing role of novel RAG2 variants and might help predict the severity of the clinical phenotype.

RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the nature of ‘alternative NHEJ’

RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair

The RAG1 N-terminal region regulates the efficiency and pathways of synapsis for V(D)J recombination

RAG-2 deficiency results in fewer phosphorylated histone H2AX foci, but increased retinal ganglion cell death and altered axonal growth

RAG1/2 induces double‐stranded DNA breaks at non‐Ig loci in the proximity of single sequence repeats in developing B cells

LRF Maintains Genome Integrity by Regulating the Non-Homologous End Joining Pathway of DNA Repair

RAG1 and RAG2 Non-core Regions Are Implicated in Leukemogenesis and Off-target V(D)J Recombination in BCR-ABL1-driven B-cell Lineage Lym-phoblastic Leukemia

Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences

Functional Redundancy Between the XLF and DNA-PKcs DNA Repair Factors in V(D)J Recombination and Nonhomologous DNA End Joining.

Nucleolar localization of RAG1 modulates V(D)J recombination activity

Disruption of the RAG2 zinc finger motif impairs protein stability and causes immunodeficiency

RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia

DNA-PKcs Suppresses Illegitimate Chromosome Rearrangements

Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability

Loss of H3K36 Methyltransferase SETD2 Impairs V(D)J Recombination During Lymphoid Development.

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

RAG2 localization and dynamics in the pre-B cell nucleus

Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells

Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement